The Effect of Ketamine on the Length of Hospital Stay of Patients Hospitalized With Suicidal Ideation.
Stopped early · Phase 4
Conditions studied: Suicidal Ideation
In brief
This study will evaluate the effect of ketamine on the treatment of patients hospitalized with suicidal thoughts. Half of the patients will receive one dose of ketamine in the vein. The other half will receive a placebo. Because we think that ketamine will improve depression and suicidal thoughts, we expect that patients who receive ketamine will require less time in the hospital than patients who receive placebo.
Key facts
- Study ID
- NCT02997722
- Run by
- Allen Richert
- People needed
- 4
- Starts
- 2017-03-02
- Expected to finish
- 2017-05-19
- Last updated by the study team
- 2020-06-02
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women between the ages of 18 and 64
- Patients admitted to the University of Mississippi Medical Center inpatient psychiatry service with suicidal ideations
You may not qualify if…
- Lifetime history of schizophrenia or other primary psychotic disorder
- Current psychotic or manic symptoms
- Substance use disorder within one month of admission
- Positive urine toxicology at admission
- Any lifetime abuse of ketamine or phencyclidine
- Systolic BP >180 mmHg or diastolic BP >110 mmHg
- Any patient who has eaten food within 8 hours prior to receiving the ketamine infusion or who has drank clear liquids within 2 hours prior to receiving the infusion
- Known central nervous system (CNS) mass
- CNS abnormalities
- Hydrocephalus
- Glaucoma
- Acute globe injury
- Porphyria
- Untreated thyroid disease
- Known coronary artery disease with poor functional capacity
- Pregnancy
- Currently breast-feeding
Where it is running
- University of Mississippi Medical Center — Jackson, Mississippi, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.